KembaraXtra – Psychology: Chlorpromazine

Chlorpromazine is a first-generation antipsychotic (also called a typical antipsychotic or neuroleptic) medication used to treat psychotic disorders and other severe mental health conditions. Introduced in the early 1950s, it was the first drug in the phenothiazine class and revolutionized the treatment of schizophrenia and related disorders. Before its development, treatment options for severe psychosis were extremely limited. Chlorpromazine made it possible for many individuals with serious mental illnesses to experience significant symptom improvement and, in many cases, live outside long-term psychiatric institutions. Its introduction marked a major turning point in modern psychiatry and psychopharmacology.

The primary action of chlorpromazine is to block dopamine receptors, particularly those involved in the brain’s mesolimbic pathway. Excessive dopamine activity has been linked to symptoms such as hallucinations, delusions, and disorganized thinking. By reducing dopamine transmission, chlorpromazine helps lessen these psychotic symptoms and promotes greater emotional and behavioral stability. The medication also has sedative properties, which can reduce agitation and severe anxiety in acute psychiatric situations. These combined effects make it valuable in the management of several psychiatric disorders.

Chlorpromazine is most commonly prescribed for schizophrenia and other psychotic disorders, but it also has additional medical uses. It may be used to treat severe mania associated with bipolar disorder, intense agitation, persistent nausea and vomiting, and certain cases of intractable hiccups. In psychiatric settings, the medication is particularly useful during acute episodes when rapid symptom control is necessary. Treatment is carefully monitored to ensure that the benefits outweigh potential adverse effects. The specific dosage depends on the individual’s condition, symptoms, and overall health.

Like many first-generation antipsychotic medications, chlorpromazine may produce a range of side effects. Common effects include drowsiness, dizziness, dry mouth, blurred vision, constipation, weight gain, and lowered blood pressure when standing. More serious adverse effects may include extrapyramidal symptoms, such as muscle stiffness, tremors, slowed movement, or involuntary muscle contractions, resulting from dopamine blockade. Long-term treatment can also increase the risk of tardive dyskinesia, a disorder involving repetitive involuntary movements. Because of these potential complications, patients receiving chlorpromazine require regular medical supervision.

From a psychological perspective, chlorpromazine represents one of the most significant milestones in the history of mental health treatment. Its discovery transformed the management of psychotic disorders and greatly advanced understanding of the role of dopamine in behavior and mental illness. Although newer second-generation antipsychotic medications are now frequently prescribed because they often produce fewer movement-related side effects, chlorpromazine continues to be used in selected clinical situations. Its development also stimulated decades of research into the biological basis of psychiatric disorders and the development of more effective psychotropic medications. Consequently, chlorpromazine remains a landmark drug in psychology, psychiatry, and neuroscience.